In hepatocellular carcinoma, Pterostilbene decreased MTA1 expression and HDAC1 activity, disrupting the MTA1/histone deacetylase complex and leading to restored PTEN acetylation and subsequent induction of apoptosis in cancer cells (Qian et al., 2018). This evidence concerns the gene MTA1 and hepatocellular carcinoma.